High Growth Tech Stocks in US Market with Promising Potential

As the U.S. market experiences slight gains, with the Dow Jones and S&P 500 inching higher amid anticipation for Nvidia's earnings report, investors are closely monitoring developments that could impact broader market sentiment. In such a dynamic environment, identifying high growth tech stocks requires careful consideration of their adaptability to current economic conditions and potential to leverage technological advancements effectively.

Name	Revenue Growth	Earnings Growth	Growth Rating
ACADIA Pharmaceuticals	10.87%	25.66%	★★★★★☆
ADMA Biologics	20.60%	23.25%	★★★★★☆
Palantir Technologies	25.17%	31.57%	★★★★★★
Workday	11.57%	30.09%	★★★★★☆
OS Therapies	57.14%	70.11%	★★★★★☆
RenovoRx	65.52%	68.83%	★★★★★☆
Circle Internet Group	27.36%	78.79%	★★★★★☆
Vanda Pharmaceuticals	22.66%	59.11%	★★★★★☆
Gorilla Technology Group	27.68%	129.58%	★★★★★☆
Aldeyra Therapeutics	42.88%	74.81%	★★★★★☆

Click here to see the full list of 67 stocks from our US High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Simply Wall St Growth Rating: ★★★★★☆

Overview: ADMA Biologics, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and marketing specialty plasma-derived biologics for treating immune deficiencies and infectious diseases globally, with a market cap of $4.06 billion.

Operations: The company generates revenue primarily from its ADMA Biomanufacturing segment, which accounts for $465.17 million, while its Plasma Collection Centers contribute $8.86 million.

ADMA Biologics showcases robust growth with a projected annual revenue increase of 20.6% and earnings expected to surge by 23.3% per year, outpacing the US market averages significantly. The company's recent financial performance underscores this trajectory, reporting a substantial year-over-year earnings growth of 500.6%, dwarfing its industry's average. In tandem with financial growth, ADMA has committed to expanding its capabilities through strategic investments in R&D, evidenced by their latest credit agreement for $300 million aimed at bolstering their operational and developmental endeavors. This approach not only secures ADMA's position in biotech innovation but also enhances its competitive edge in a rapidly evolving sector.

ADMA Revenue and Expenses Breakdown as at Aug 2025

Simply Wall St Growth Rating: ★★★★★☆

Overview: Cellebrite DI Ltd. provides solutions for legally sanctioned investigations across various regions including Europe, the Middle East, Africa, the Americas, and the Asia-Pacific with a market cap of $3.87 billion.

Operations: Cellebrite DI Ltd. generates revenue primarily from its Internet Software & Services segment, amounting to $436.73 million.

Cellebrite DI Ltd. has demonstrated a notable turnaround with its recent earnings results, reporting a net income of $36.88 million for the half-year ended June 30, 2025, a significant recovery from a net loss of $95.18 million in the previous year. This financial rebound is supported by an impressive annualized revenue growth rate of 14.3% and an expected earnings growth of 67.7% per annum, positioning the company favorably against industry norms. The firm's commitment to innovation is evident from its R&D spending trends which have strategically bolstered its product offerings in digital forensics—a sector gaining traction due to increasing cybersecurity demands globally.

CLBT Earnings and Revenue Growth as at Aug 2025

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Viant Technology Inc. is an advertising technology company with a market cap of $621.33 million.

Operations: Viant Technology generates revenue primarily through its enterprise software platform, which brought in $318.47 million.

Viant Technology's recent strategic alliances and technological innovations underscore its potential within the high-growth tech sector. The company's partnership with AdTegral, marking it as the exclusive DSP activation partner, enhances its Connected TV (CTV) and AI capabilities, crucial for small to mid-sized advertisers aiming for optimized campaign performance without hefty media budgets. This collaboration follows Viant's integration with Wurl to deliver scene-level contextual intelligence in CTV advertising—a first in the industry—further solidifying its leadership in programmatic advertising solutions. These advancements are supported by a robust financial performance with Q2 sales rising to $77.85 million from $65.87 million year-over-year, alongside a modest net income increase to $0.29 million from $0.055 million, reflecting Viant's effective strategy and execution in expanding its technological footprint and market reach.

DSP Revenue and Expenses Breakdown as at Aug 2025

Click here to access our complete index of 67 US High Growth Tech and AI Stocks.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ADMA CLBT and DSP.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com